New York, NY -- (SBWIRE) -- 12/05/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Rite Aid Corporation (NYSE:RAD), Hercules Offshore, Inc (NASDAQ:HERO), Oculus Innovative Sciences, Inc (NASDAQ:OCLS), Lustros Inc (OTCMKTS:LSTS)
Rite Aid Corporation (NYSE:RAD) the stock opened the session at $6.15 but then moved to $6.00. At that price, the stock showed a negative performance of -1.80%. Rite Aid Corporation is a retail drugstore chain in the United States. As of March 3, 2013, it operated 4,623 stores in 31 states across the country and in the District of Columbia. In the Company’s stores, it sells prescription drugs and a range of other merchandise, which it calls front end products. During the fiscal year ended March 3, 2013 (fiscal 2013), prescription drug sales accounted for 67.6% of its total sales. It carries a range of front end products, which accounted for 32.4% of its total sales in fiscal 2013. Front end products include over-the-counter medications, health and beauty aids, personal care items,
Will RAD Get Buyers Even After The Recent Rally? Find Out Here
Hercules Offshore, Inc (NASDAQ:HERO) opened the session at $6.26 and closed the session at $6.42. The stock showed a positive performance of 2.88% in previous trading session. Traded with volume of 2.58 million shares in the prior session and the average volume of the stock remained 2.84 million shares. Hercules Offshore, Inc. (Hercules Offshore) provides shallow-water drilling and marine services to the oil and natural gas exploration and production industry globally. It provides these services to national oil and gas companies, integrated energy companies and independent oil and natural gas operators. As of February 23, 2012, it owned a fleet of 42 jackup rigs,
For How Long HERO will fight for Profitability? Read This Trend Analysis report
Oculus Innovative Sciences, Inc (NASDAQ:OCLS) opened the session at $6.05and closed the session at $4.74. The stock showed a positive performance of 103.43% in previous trading session. The beta of the stock remained 1.17. Oculus Innovative Sciences, Inc. is a global healthcare company that designs, produces, and markets prescription and non-prescription products in over 20 countries.The Company’s focus is on the commercialization of its technology platform called Microcyn Technology. Outside the United States, its Microcyn Technology products have a CE Mark device approval in Europe for debriding,
Why Should Investors Buy OCLS After The Recent Gain? Just Go Here and Find Out
Lustros Inc (OTCMKTS:LSTS) the stock advanced 28.36% and finished the session at $0.430. Traded with volume of 836,311.00 shares in the prior session and the average volume of the stock remained 369,174.00 shares. The beta of the stock remained 0.89. Lustros, Inc. is a development-stage company. The Company manufactures copper sulfate from traditional mining and leftover tailings. The Company's manufacturing facilities are located in Chile, South America. In October 2013, Lustros Inc announced that its subsidiary, Sulfatos Chile SA, completed its first sale of Pentahyrdate Copper Sulfate.
Will LSTS Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)